• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic appoints Pfizer EVP as independent board director

Medtronic appoints Pfizer EVP as independent board director

June 27, 2022 By Sean Whooley

Portrait photo of Pfizer EVP and Medtronic board member Lidia Fonseca
Lidia Fonseca is EVP and chief digital and technology officer at Pfizer [Image courtesy of Fonseca]
Medtronic (NYSE:MDT) announced today that it appointed Lidia Fonseca to its board of directors as an independent director.

Fonseca, who serves as EVP and chief digital and technology officer at Pfizer, will become a director effective today. She will serve on the board’s Compensation Committee and Science and Technology Committee.

“We are thrilled to welcome Lidia to Medtronic’s board of directors,” Medtronic Chair and CEO Geoff Martha said in a news release. “She has an impressive history of developing digital healthcare solutions that deliver powerful insights to improve patients’ lives. Her extensive knowledge and expertise will provide the board with an important dimension and a tremendously valuable perspective as we drive toward our bold ambition to become the global leader in healthcare technology.”

With more than 30 years of experience in healthcare innovation, Fonseca currently holds responsibility for developing and implementing an enterprise-wide digital strategy and leading all digital, data and technology solutions at Pfizer. She’s also responsible for Pfizer Learning and Development and Business Process Excellence.

Medtronic said Fonseca spearheads a range of innovative programs and initiatives, including ones for digitizing drug discovery and development, improving health outcomes and patient experiences through digital health, medicines and diagnostics, advancing operational processes through automation and robotics, and delivering insights with analytics and artificial intelligence.

Fonseca’s most recent work includes leading Pfizer’s digital team as part of the effort to develop the company’s COVID-19 vaccine. She also led efforts to create Pfizer’s advanced analytics platform for combining data and tools from the company and external partners to model scientific and clinical decisions, patterns and insights.

Before Pfizer, Fonseca served as SVP and chief information officer (CIO) at Quest Diagnostics from 2014 to 2018. She was responsible for technology, informatics and digital solutions at Quest. Before that, she was SVP and CIO at Labcorp from 2008 to 2013.

Filed Under: Big Data, Business/Financial News, Digital Health, Electronic Medical Records (EMR), Featured, Health Technology, Pharmaceutical, Software / IT, Surgical Robotics Tagged With: Medtronic, Personnel Moves

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy